Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

European Clinical Research Alliance for Infectious Diseases (ECRAID) clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our France, Spain, Belgium, Italy, Netherlands, Germany and Czechia registers with European Clinical Research Alliance for Infectious Diseases (ECRAID) as lead sponsor. Synced 14 Nov 2026
4Current trials
3Recruiting now
0Drugs in these trials
7Trial registers
At a glance

European Clinical Research Alliance for Infectious Diseases (ECRAID) is the lead sponsor of 4 current clinical trials in our France, Spain, Belgium, Italy, Netherlands, Germany and Czechia registers. 3 are recruiting patients now. All registered phases are Observational. The most-studied condition is Acute Respiratory Tract Infection.

ClinicalTrials.gov trials by status

  • Recruiting375%
  • Active, closed125%

Trials by phase

  • Observational4100%
01

Clinical trials sponsored by European Clinical Research Alliance for Infectious Diseases (ECRAID)

4 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
POS-ARI-ER Observational Study of Acute Respiratory Infections
NCT05814237 · ClinicalTrials.gov ↗ · Acute Respiratory Infection, Acute Respiratory Tract Infection
Observational Recruiting 2023-06 France, Spain, Italy, Netherlands, Belgium
A Long-term Observational Study Evaluating the Presentation and Management of Acute Respiratory Tract Infections in Primary Care Across Europe
NCT06282718 · ClinicalTrials.gov ↗ · Acute Respiratory Tract Infection
Observational Recruiting 2024-02 France, Belgium
POS-cUTI: Study on Complicated Urinary Tract Infections
NCT05458700 · ClinicalTrials.gov ↗ · Urinary Tract Infections
Observational Recruiting 2022-10 Spain
Perpetual Observational Study - Ventilator Associated Pneumonia
NCT05719259 · ClinicalTrials.gov ↗ · Ventilator Associated Pneumonia
Observational Active, closed 2022-08 Germany, France, Spain, Italy, Netherlands, Belgium, Czechia

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in European Clinical Research Alliance for Infectious Diseases (ECRAID) trials

4 conditions
Acute Respiratory Tract Infection2Ventilator Associated Pneumonia1Acute Respiratory Infection1Urinary Tract Infections1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in France32
Clinical trials in Spain32
Clinical trials in Belgium32
Clinical trials in Italy21
Clinical trials in Netherlands21
Clinical trials in Germany10
Clinical trials in Czechia10

A trial with sites in more than one country appears in each of those registers.

04

Questions about European Clinical Research Alliance for Infectious Diseases (ECRAID) trials

How many clinical trials does European Clinical Research Alliance for Infectious Diseases (ECRAID) sponsor?

European Clinical Research Alliance for Infectious Diseases (ECRAID) is the lead sponsor of 4 current trials on ClinicalTrials.gov in our France, Spain, Belgium, Italy, Netherlands, Germany and Czechia registers, as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.

Are European Clinical Research Alliance for Infectious Diseases (ECRAID) trials recruiting?

Yes. 3 of its 4 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.